Corticosteroids are effective at inducing remission in patients with ulcerative colitis (UC); however, it is not known if adding mesalamine confers additional benefits in the acute setting. In a ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Older patients with Crohn’s disease were less likely to receive biologic agents and more than ...

Please provide your email address to receive an email when new articles are posted on . A once-daily dose of MMX mesalamine may be noninferior to a twice-daily dose of delayed-release mesalamine for ...

October 28, 2010 (San Antonio, Texas) — A delayed-release formulation of the anti-inflammatory drug mesalamine showed efficacy in the treatment of diverticulitis at 12 weeks and continued improvement ...

November 3, 2009 (San Diego, California) — In clinical trial results that surprised even the investigators, delayed-release mesalamine (Asacol HD, Procter & Gamble) once a day was as effective as a ...

Credit: Shutterstock. The 35-year-old male from Hawaii maintained clinical remission with Lialda, a once-daily formulation of mesalamine, and infliximab. A switch in the oral formulation of mesalamine ...

October 15, 2007, Philadelphia, PA – Researchers found that mesalamine use among patients with inflammatory bowel disease was associated with a decrease in incidence of colorectal cancer when ...

“Given the minimal adverse events, we recommend that curcumin be considered as an adjunct to mesalamine in the treatment of UC.” Adjunctive therapy with curcumin was found to provide a greater ...